Pular para o conteúdo
  • Institutional prijava
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
    • Māori
    • தமிழ்
Napredno
  • S226: EFFICACY OF ANTI-PD1 THE...
  • Citiraj
  • Pošljite email
  • Natisni
  • Izvozi zadetek
    • Izvozi v RefWorks
    • Izvozi v EndNoteWeb
    • Izvozi v EndNote
    • Izvozi v BibTeX
    • Izvozi v RIS
  • Dodaj v priljubljene
  • Link permanente
Nalaganje...
Slika na naslovnici

QR koda

S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA

Shranjeno v:
Bibliografske podrobnosti
Principais autores: Amira Marouf, Sammara Chaubard, Jean Marie Michot, Julien Rossignol, Camille Golfier, Olivier Allangba, Laure Philippe, Benoit Tessoulin, Adrien Chauchet, Bénédicte Deau, Lucie Oberic, Jacques Vargaftig, Aline Moignet, Aline Clavert, Rémy Duléry, Gabriel Brisou, Stéphanie Tardy, Virginie Fataccioli, Roch Houot, Rene Olivier Casasnovas, Catherine Thieblemont, Herve Ghesquieres, Sylvain Carras, Steven Le Gouill, Guillaume Cartron, Aurélien Marabelle, Olivier Tournilhac, Gandhi Laurent Damaj, Philippe Gaulard, Laurence De Leval, Francois Lemonnier, Emmanuel Bachy, Olivier Hermine, Lucile Couronné, Arnaud Jaccard
Format: Artigo
Jezik:Inglês
Izdano: Wiley 2023-08-01
Serija:HemaSphere
Online dostop:http://journals.lww.com/10.1097/01.HS9.0000967816.41118.bf
Oznake: Označite
Brez oznak, prvi označite!
  • Zaloga
  • Opis
  • Komentarji
  • Predogled
  • Podobne knjige/članki
  • Knjižničarski pogled

Podobne knjige/članki

  • S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA
    od: Amira Marouf, et al.
    Izdano: (2023-08-01)
  • P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
    od: Clementine Sarkozy, et al.
    Izdano: (2023-08-01)
  • Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry
    od: Federico Erbella, et al.
    Izdano: (2026-01-01)
  • Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
    od: Clémentine Sarkozy, et al.
    Izdano: (2025-04-01)
  • Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA Group
    od: Marion Aymard, et al.
    Izdano: (2026-01-01)

Iskalne možnosti

  • Iskalna zgodovina
  • Napredno iskanje

Poišči več

  • Prelistaj katalog
  • Po abecedi
  • Explorar canais
  • Obvezna literatura
  • Novi knjige/članki

Potrebujete pomoč?

  • Navodila za iskanje
  • Vprašaj knjižničarja
  • Pogosta vprašanja